ATE454450T1 - Proteine, das auf hämatopoietischen stammzellen der lymphoid und nk linien zu finden ist, und verwendungen davon - Google Patents

Proteine, das auf hämatopoietischen stammzellen der lymphoid und nk linien zu finden ist, und verwendungen davon

Info

Publication number
ATE454450T1
ATE454450T1 AT00981414T AT00981414T ATE454450T1 AT E454450 T1 ATE454450 T1 AT E454450T1 AT 00981414 T AT00981414 T AT 00981414T AT 00981414 T AT00981414 T AT 00981414T AT E454450 T1 ATE454450 T1 AT E454450T1
Authority
AT
Austria
Prior art keywords
protein
positions
cells
hematopoietic stem
sequence
Prior art date
Application number
AT00981414T
Other languages
English (en)
Inventor
Marek Kirszenbaum
Discorde Magali Le
Stephane Prost
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE454450T1 publication Critical patent/ATE454450T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00981414T 1999-11-12 2000-11-10 Proteine, das auf hämatopoietischen stammzellen der lymphoid und nk linien zu finden ist, und verwendungen davon ATE454450T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914241A FR2801056B1 (fr) 1999-11-12 1999-11-12 Proteine presente a la surface des cellules souches hematopoietiques de la lignee lymphoide et des cellules nk, et ses applications
PCT/FR2000/003137 WO2001034653A2 (fr) 1999-11-12 2000-11-10 Proteine presente a la surface des cellules souches hematopoietiques de la lignee lymphoide et des cellules nk, et ses applications.

Publications (1)

Publication Number Publication Date
ATE454450T1 true ATE454450T1 (de) 2010-01-15

Family

ID=9552057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981414T ATE454450T1 (de) 1999-11-12 2000-11-10 Proteine, das auf hämatopoietischen stammzellen der lymphoid und nk linien zu finden ist, und verwendungen davon

Country Status (8)

Country Link
US (2) US7235632B1 (de)
EP (1) EP1228212B1 (de)
JP (1) JP2003516130A (de)
AT (1) ATE454450T1 (de)
CA (1) CA2389204A1 (de)
DE (1) DE60043664D1 (de)
FR (1) FR2801056B1 (de)
WO (1) WO2001034653A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009002414A (es) 2006-09-08 2009-05-20 Medimmune Llc Anticuerpos anti-cd19 humanizados y su uso en el tratamiento de oncologia, transplante y enfermedad autoinmunitaria.
US8894197B2 (en) 2007-03-01 2014-11-25 Seiko Epson Corporation Ink set, ink-jet recording method, and recorded material
CA3095576A1 (en) * 2009-12-04 2011-06-09 Astellas Institute For Regenerative Medicine Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts
US9770504B2 (en) * 2013-05-03 2017-09-26 The Board Of Regents Of The University Of Texas System Generating peptoid vaccines
WO2018056736A1 (ko) * 2016-09-23 2018-03-29 주식회사 에스엘바이젠 신규 자연살해 세포주 및 그의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0714510B1 (de) * 1993-08-27 2002-06-19 Dana Farber Cancer Institute Für natürliche killerzellen spezifische antigene und sie identifizierende antikörper
WO1995020604A1 (en) * 1994-01-28 1995-08-03 Schering Corporation Antibodies to mammalian natural killer antigens and uses
JP2001505783A (ja) * 1996-12-11 2001-05-08 カイロン コーポレイション 分泌ヒトタンパク質
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
CA2283299A1 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
CA2311572A1 (en) * 1997-12-17 1999-06-24 Genset S.A. Extended cdnas for secreted proteins
JP2002522062A (ja) * 1998-08-14 2002-07-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
AU6181300A (en) * 1999-07-29 2001-02-19 Helix Research Institute Liver cancer-associated genes
EP1206536A2 (de) * 1999-08-17 2002-05-22 Sagami Chemical Research Center Menschliche proteine mit hydrophoben domänen und dafür kodierende dnas
US7235623B2 (en) * 2003-11-26 2007-06-26 Eastman Chemical Company Polyester compositions for calendering

Also Published As

Publication number Publication date
JP2003516130A (ja) 2003-05-13
FR2801056B1 (fr) 2003-03-28
US7235632B1 (en) 2007-06-26
FR2801056A1 (fr) 2001-05-18
US20070148686A1 (en) 2007-06-28
DE60043664D1 (de) 2010-02-25
CA2389204A1 (en) 2001-05-17
WO2001034653A3 (fr) 2002-02-07
EP1228212A2 (de) 2002-08-07
EP1228212B1 (de) 2010-01-06
WO2001034653A2 (fr) 2001-05-17

Similar Documents

Publication Publication Date Title
Sugrue et al. Immunoidentification of type XII collagen in embryonic tissues.
Vaughan et al. A major, six‐armed glycoprotein from embryonic cartilage.
Suzuki et al. cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors.
Kadoya et al. Antibodies against domain E3 of laminin-1 and integrin alpha 6 subunit perturb branching epithelial morphogenesis of submandibular gland, but by different modes.
Weining et al. A chicken homolog of mammalian interleukin‐1β: cDNA cloning and purification of active recombinant protein
Politz et al. Stabilin-1 and− 2 constitute a novel family of fasciclin-like hyaluronan receptor homologues
Welcher et al. A myelin protein is encoded by the homologue of a growth arrest-specific gene.
Toyoshima et al. Collagen-binding domain of a Clostridium histolyticum collagenase exhibits a broad substrate spectrum both in vitro and in vivo
NZ334035A (en) Use of endokine alpha antagonists to diagnose and treat TNF-related disorders
RU2002124123A (ru) Модифицированный фактор viii
JPH03500046A (ja) フィブロネクチン活性を有するポリペプチド
WO2000034474A3 (en) Growth factor homolog zvegf3
KR950704497A (ko) 글리코실트랜스퍼라제 활성을 가진 단백질(Proteins Having Glycosyltransferase Activity)
Davis et al. Basic fibroblast growth factor induces 3T3 fibroblasts to synthesize and secrete a cyclophilin-like protein and β2-microglobulin
Abrams et al. Molecular cloning of the microfibrillar protein MFAP3 and assignment of the gene to human chromosome 5q32–q33. 2
JPH06503966A (ja) 生合成したｐｄｇｆアンタゴニスト
DE69926627D1 (de) Insulinartigen wachstumsfaktor bindendes protein -3 variante
ATE454450T1 (de) Proteine, das auf hämatopoietischen stammzellen der lymphoid und nk linien zu finden ist, und verwendungen davon
US5493008A (en) Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain
Syfrig et al. An abundant chick gizzard integrin is the avian α1β1 integrin heterodimer and functions as a divalent cation-dependent collagen IV receptor
DE69133159D1 (de) Chemotaktische faktoren
Ehnis et al. Localization of a cell adhesion site on collagen XIV (undulin)
JPH01206998A (ja) 細胞接着活性ポリペプチド
Glansbeek et al. Expression of Recombinant Human Soluble Type II Transforming Growth Factor-β Receptor inPichia pastorisandEscherichia coli: Two Powerful Systems to Express a Potent Inhibitor of Transforming Growth Factor-β
NO20020012L (no) Reseptor for neurotrofisk faktor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties